European Investors Pivot To Deep Tech – Part I
A realignment of investor and sovereign interests across Europe has led to an emerging renaissance in deep tech. It is a huge opportunity for entrepreneur science researchers.
Investment
Read More
Winter Of Discontent For Antipodean Science Innovators and Investors
The precipitous cancellation of Australia’s Economic Accelerator (AEA) this month, alongside the redirection of $800 million in uncommitted funding, has sent a shock wave through their research, science and technology sector.
Kenyan Wildlife Trip Inspires Biotech Startup
Touted as “one to watch” in biotech investor circles, German biopharmaceutical company Kupando is advancing a disruptive dual approach that could both reduce solid tumours and counter infectious diseases.
Standing Ovation For €30 Million Foodtech Funding
Paris based company Standing Ovation specialises in producing animal-free casein through precision fermentation. They just raised an impressive €30 million as part of French efforts to preserve technical sovereignty and secure future food supply.
Sunny Future For Synthetic Leaf Venture
UK-Portugal greentech venture Arborea is bridging the gap between design engineering and biotechnology with a synthetic leaf that creates food directly from sunlight.
Samsara Eco Races To Recycle Nylon Fast Fashions
A spinoff company from the Australian National University plans to shake up the garment industry through enzymatic recycling of polyester.
EC Green Lights “EU Inc” Proposal
EU Inc, a new pan-European legal entity structure, proposed by the European Commission, aims to simplify company incorporation, investment and acquisitions for startup ventures across the European Union.
Wellumio Solves Golden Hour Headache
New Zealand deep tech startup Wellumio is developing a portable NMR scanner that delivers quicker patient care and better outcomes.
Spatial Omics Sparks Stockholm Success
A Swedish biotech startup is making waves in the field of 3D “spatial biology” for transcriptomics – a game changer for accelerated development of drug therapies.